SIG | Tuberous Sclerosis: The Role of EEG Interictal Epileptiform Activity in Diagnosing and Treating Tuberous Sclerosis Complex

Friday, December 3, 2021
-

You may need to log in to view video on this page.

OVERVIEW:

This Special Interest Group assesses the role of EEG interictal epileptiform activity as a biomarker, the impact of interictal epileptiform activity on behavior and cognition, and the use of advanced analytical techniques, machine learning, and connectivity measures with interictal epileptiform activity.

Learning Objectives:

Following participation in this activity, participants will be able to:

  • Discuss the role of EEG interictal epileptiform activity as a biomarker in tuberous sclerosis complex
  • Identify the potential impact of EEG interictal epileptiform activity on behavior and cognition in tuberous sclerosis complex
  • Examine the potential role of advanced analytical tools in assessing EEG interictal epileptiform activity in tuberous sclerosis complex

Program:

SIG Coordinators: Joyce W. Wu, MD, Brenda Porter, MD, PhD, and Howard Weiner, MD

Chair: Joyce W. Wu, MD

The Use of EEG Interictal Epileptiform Activity as a Biomarker | Joyce W. Wu, MD

The Impact of EEG Interictal Epileptiform Activity on Behavior and Neurocognition | Lieven Lagae, MD

The Use of Advanced Analytical Techniques on EEG Interictal Epileptiform Activity | Peter Davis, MD 

Education Credit:

This educational activity is supported in part by Upsher-Smith Laboratories, LLC 

Activity Type
Special Interest Group
Credit
Non-CME
Format
In person
Career Stage
Early Career (typically 0-5 years from completion of training)
Mid-Career (typically 6-15 years from completion of training)
Senior (typically >15 years from completion of training)
Audience
Advanced Practice Providers
Behavioral Health Providers
Clinicians
Fellows/Trainees
Nurses
Pharmacists
Scientists/Researchers
Technicians
Demographic
Clinical
First-time Attendees
Research